The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP.

There has never been a definite consensus on the classification and diagnostic criteria for the hypertensive disorders of pregnancy. This uncertainty is likely to have led to between-centre differences in rates of adverse maternal and foetal outcomes for the various hypertensive disorders in pregnancy, particularly pre-eclampsia. In 2000, the International Society for the Study of Hypertension in Pregnancy (ISSHP) recognised that this lack of consensus was one reason for controversies concerning counselling, management and documentation of immediate and remote pregnancy outcomes. Accordingly, the Society appointed a committee that reviewed available classifications and endorsed and published an international recommendation for how these disorders should be classified and diagnosed in pregnancy [1]. The major stumbling block remained whether or not proteinuria should be retained as a sine qua non for the diagnosis of pre-eclampsia; the Society recommended that a broad definition, at times not including proteinuria, could be applied for the clinical definition of pre-eclampsia whilst the inclusion of proteinuria would ensure more specificity around the diagnosis when reporting clinical criteria for patients enrolled in scientific research. The purpose of this document is to update ISSHP thinking on this subject.

[1]  François Audibert,et al.  Prevention of Preeclampsia and Intrauterine Growth Restriction With Aspirin Started in Early Pregnancy: A Meta-Analysis , 2010, Obstetrics and gynecology.

[2]  G. Gitas,et al.  Biomarkers in pre-eclampsia: A novel approach to early detection of the disease , 2012, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

[3]  A. Seidler,et al.  Antiplatelet agents for preventing pre-eclampsia and its complications. , 2007, The Cochrane database of systematic reviews.

[4]  M. Brown,et al.  Improved methods of assessing proteinuria in hypertensive pregnancy , 1997, British journal of obstetrics and gynaecology.

[5]  K. Lim,et al.  Angiogenic Factors and the Risk of Adverse Outcomes in Women With Suspected Preeclampsia , 2012, Circulation.

[6]  G. D'ottavio,et al.  First trimester maternal serum PIGF, free β-hCG, PAPP-A, PP-13, uterine artery Doppler and maternal history for the prediction of preeclampsia. , 2012, Placenta.

[7]  M. Mugglestone,et al.  Management of hypertensive disorders during pregnancy: summary of NICE guidance , 2010, BMJ : British Medical Journal.

[8]  James M. Roberts,et al.  If we know so much about preeclampsia, why haven't we cured the disease? , 2013, Journal of reproductive immunology.

[9]  F. Epstein,et al.  Circulating angiogenic factors in gestational proteinuria without hypertension. , 2007, American journal of obstetrics and gynecology.

[10]  G. V. van Montfrans,et al.  Validation of the Omron M7 and Microlife 3BTO-A Blood Pressure Measuring Devices in Preeclampsia , 2012, Hypertension in pregnancy.

[11]  J. Hutcheon,et al.  Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model , 2011, The Lancet.

[12]  Diagnosis, Evaluation, and Management of the Hypertensive Disorders of Pregnancy , 2008 .

[13]  A. Shennan,et al.  Hidden errors of aneroid sphygmomanometers , 2002, Blood pressure monitoring.

[14]  Z. Bhutta,et al.  PIERS proteinuria: relationship with adverse maternal and perinatal outcome. , 2011, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[15]  M. Brown,et al.  Is resistant hypertension really resistant? , 2001, American journal of hypertension.

[16]  C. Ris-Stalpers,et al.  Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms‐like tyrosine kinase 1 and soluble endoglin in the prediction of pre‐eclampsia: a systematic review and meta‐analysis , 2012, BJOG : an international journal of obstetrics and gynaecology.

[17]  L. Magee,et al.  The 24-hour urine collection: gold standard or historical practice? , 2008, American journal of obstetrics and gynecology.

[18]  B. Payne,et al.  Performance of the fullPIERS model in predicting adverse maternal outcomes in pre‐eclampsia using patient data from the PIERS (Pre‐eclampsia Integrated Estimate of RiSk) cohort, collected on admission , 2013, BJOG : an international journal of obstetrics and gynaecology.

[19]  C. Homer,et al.  Non-proteinuric pre-eclampsia: a novel risk indicator in women with gestational hypertension , 2008, Journal of hypertension.

[20]  D. Charnock-Jones,et al.  Redefining preeclampsia using placenta-derived biomarkers. , 2013, Hypertension.

[21]  R. Riley,et al.  Diagnostic accuracy of spot urinary protein and albumin to creatinine ratios for detection of significant proteinuria or adverse pregnancy outcome in patients with suspected pre-eclampsia: systematic review and meta-analysis , 2012, BMJ : British Medical Journal.

[22]  G. Mangos,et al.  Can spot urine protein/creatinine ratio replace 24 h urine protein in usual clinical nephrology? , 2006, Nephrology.

[23]  H. Odendaal,et al.  Do women with pre-eclampsia and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial , 2002 .

[24]  R. Ness,et al.  Uric Acid Is as Important as Proteinuria in Identifying Fetal Risk in Women With Gestational Hypertension , 2005, Hypertension.

[25]  R. Liston,et al.  The Active Implementation of Pregnancy Hypertension Guidelines in British Columbia , 2010, Obstetrics and gynecology.

[26]  D. Henderson-smart,et al.  Antiplatelet agents for preventing pre-eclampsia and its complications. , 2007, The Cochrane database of systematic reviews.

[27]  M. Brown,et al.  Does gestational hypertension become pre‐eclampsia? , 1998, British journal of obstetrics and gynaecology.

[28]  Á. Atallah,et al.  Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. , 2002, The Cochrane database of systematic reviews.

[29]  R. Liston,et al.  Diagnostic accuracy of urinary spot protein:creatinine ratio for proteinuria in hypertensive pregnant women: systematic review , 2008, BMJ : British Medical Journal.

[30]  R. Haslam,et al.  Antioxidants for preventing pre-eclampsia. , 2008, The Cochrane database of systematic reviews.

[31]  R. T. Lie,et al.  The Interval Between Pregnancies and the Risk of Preeclampsia , 2002 .

[32]  B. Sibai,et al.  Abortion, changed paternity, and risk of preeclampsia in nulliparous women. , 2003, American journal of epidemiology.

[33]  M. Brown Pre-eclampsia: Proteinuria in pre-eclampsia—does it matter any more? , 2012, Nature Reviews Nephrology.

[34]  B. Peretz The white coat. , 2010, Refu'at ha-peh veha-shinayim.

[35]  A. Gülmezoglu,et al.  Anticonvulsants for women with pre-eclampsia. , 2000, The Cochrane database of systematic reviews.

[36]  M. Brown,et al.  A Prospective Study of the Impact of Automated Dipstick Urinalysis on the Diagnosis of Preeclampsia , 2004, Hypertension in pregnancy.

[37]  M. Brown,et al.  Is there a role for ambulatory blood pressure monitoring in pregnancy? , 2014, Clinical and experimental pharmacology & physiology.

[38]  Michael A Black,et al.  Clinical risk prediction for pre-eclampsia in nulliparous women: development of model in international prospective cohort , 2011, BMJ : British Medical Journal.

[39]  S. Roberts,et al.  Prediction of pre‐eclampsia in early pregnancy by estimating the spot urinary albumin: creatinine ratio using high‐performance liquid chromatography , 2011, BJOG : an international journal of obstetrics and gynaecology.

[40]  Jan A Staessen,et al.  White-coat hypertension: new insights from recent studies. , 2013, Hypertension.

[41]  B. Sibai,et al.  The definition of severe and early-onset preeclampsia. Statements from the International Society for the Study of Hypertension in Pregnancy (ISSHP). , 2013, Pregnancy hypertension.

[42]  G. Davis,et al.  Can We Use the Omron T9P Automated Blood Pressure Monitor in Pregnancy? , 2011, Hypertension in pregnancy.

[43]  M. Lindheimer,et al.  Interpreting Abnormal Proteinuria in Pregnancy: The Need for a More Pathophysiological Approach , 2010, Obstetrics and gynecology.

[44]  M. Greene,et al.  De Swiet's medical disorders in obstetric practice , 2010 .

[45]  G. Saade,et al.  First-Trimester Prediction of Preeclampsia in Nulliparous Women at Low Risk , 2012, Obstetrics and gynecology.

[46]  Catherine M. Brown,et al.  Hypertension in pregnancy: is it time for a new approach to treatment? , 2012, Journal of hypertension.

[47]  D. A. Green,et al.  New Insights From Recent Studies in Historical Astronomy: Following in the Footsteps of F. Richard Stephenson , 2015 .

[48]  R. Rodrigo,et al.  Prediction of early and late pre‐eclampsia from maternal characteristics, uterine artery Doppler and markers of vasculogenesis during first trimester of pregnancy , 2013, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[49]  Jean-Marie Moutquin,et al.  The Classification and Diagnosis of the Hypertensive Disorders of Pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP) , 2001, Hypertension in pregnancy.

[50]  G. Dekker,et al.  Duration of sexual relationship and its effect on preeclampsia and small for gestational age perinatal outcome. , 2009, Journal of reproductive immunology.

[51]  B. Sibai,et al.  Cardiology patient page. Chronic hypertension in pregnancy. , 2007, Circulation.

[52]  J. Langhoff‐Roos,et al.  Thrombophilias and adverse pregnancy outcomes: results from the Danish National Birth Cohort , 2012, Journal of thrombosis and haemostasis : JTH.

[53]  G. Dekker,et al.  Guidelines for the management of hypertensive disorders of pregnancy 2008 , 2009, The Australian & New Zealand journal of obstetrics & gynaecology.

[54]  A. Polyakov,et al.  The accuracy of spot urinary protein‐to‐creatinine ratio in confirming proteinuria in pre‐eclampsia , 2012, The Australian & New Zealand journal of obstetrics & gynaecology.

[55]  C. Homer,et al.  The natural history of white coat hypertension during pregnancy , 2005, BJOG : an international journal of obstetrics and gynaecology.